News Samsung Bioepis signs R&D agreement with Takeda South Korean firm looking to develop novel drugs
News Takeda begins new R&D link-up with Molecular Templates Takeda is increasing its R&D investment in oncology with a collaboration with Texas biotech Molecular Templates.
News Seattle, Takeda aim for first line Adcetris use Seattle CEO hopes Adcetris will be standard of care.
News AZ highlights data from next-gen oncology drugs at ASCO Tesara and Takeda among other companies to publish data.
News GW close to filing cannabis-based epilepsy drug Epidiolex could become a blockbuster if approved in all uses.
News Takeda signs deal with UK biotech GammaDelta Therapeutics on... UK biotech pioneering new type of T cell immunotherapy
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
